11 unknown, 10 completed, 3 withdrawn, 2 terminated. 27 Phase 2, 7 Phase 3, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 27 | Unknown 11, Completed 10, Withdrawn 3, Terminated 2, Recruiting 1 |
| Phase 3 | 7 | Unknown 4, Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 1 | 5 | Completed 2, Unknown 2, Terminated 1 |
Follow Riboflavin: new trials by email Literature Review of Riboflavin trials Research Report on Riboflavin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia Riboflavin 0.1% ophthalmic solution and pulsed light, Riboflavin 0.1% ophthalmic solution and non-pulsed light - Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Recruiting | Price Vision Group | 500 | 2025-10-01 | 2026-09-25 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 488 | 2022-03-14 | 2022-10-28 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care Therapy + Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 468 | 2022-03-14 | 2022-10-28 |
| Riboflavin for Glutamate Reduction in Alcohol Withdrawal Riboflavin, Placebo - Alcohol Withdrawal, Nutrition Disorders | Phase 2 | Unknown | Oregon Health and Science University | 40 | 2021-12-01 | 2021-09-29 |
| Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position PXL 330 Platinum device/Riboflavin - Keratoconus, Unstable, Ectasia Corneal | Phase 2 | Completed | Eye Specialists of Indiana | 12 | 2020-05-04 | 2024-08-29 |
| Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure Oral Riboflavin - Axial Myopia, Refractive Errors | Phase 2 | Withdrawn | University of Missouri-Columbia | 2018-10-10 | 2026-08-24 | |
| A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis ISIS 416858, Placebo - End-stage Renal Disease (ESRD) | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 213 | 2017-12-26 | 2023-01-20 |
| Ramelteon in the Prevention of Post-operative Delirium Ramelteon, Microcrystalline Cellulose, Riboflavin 100 mg - Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders | Phase 2 | Completed | Johns Hopkins University | 80 | 2017-03-24 | 2020-06-30 |
| Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit Riboflavin, Dextran, UVA Light Source - Keratolysis | Phase 1 / Phase 2 | Completed | Joseph B. Ciolino, MD | 76 | 2017-03-15 | 2023-05-10 |
| Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota Riboflavin Dose 1, Riboflavin Dose 2, Placebo - Gut Microbiota | Phase 2 | Completed | dsm-firmenich Switzerland AG | 105 | 2016-11-01 | 2020-01-22 |
| The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis Riboflavin, Placebo - Psoriasis | Phase 2 | Completed | University of Michigan | 23 | 2016-08-11 | 2022-07-28 |
| The Impact of Riboflavin on Sports-related Concussion Riboflavin, Placebo - Sports-related Concussion | Phase 2 | Unknown | University of Virginia | 500 | 2016-08-01 | 2017-08-11 |
| Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain acetazolamide, Quinine, Riboflavin - Compliance, Chronic Pain | Phase 2 | Withdrawn | Georgetown University | 2014-12-01 | 2017-02-10 | |
| Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus adjusted corneal collagen cross-linking, accelerated corneal collagen cross-linking, riboflavin 0.1% combined with dextran 20 % - Keratoconus | Phase 1 / Phase 2 | Unknown | Tehran University of Medical Sciences | 40 | 2014-08-01 | 2015-07-23 |
| Treatment of Keratoconus With Advanced CXL-II Topography-based CXL (KXL2), Conventional pulsed CXL (pCXL), Riboflavin - Keratoconus | Phase 2 | Unknown | Umeå University | 50 | 2014-03-01 | 2018-05-16 |
| The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial) Methotrexate, Riboflavin - Myocardial Infarction | Phase 2 | Unknown | Instituto de Cardiologia do Rio Grande do Sul | 80 | 2013-04-01 | 2013-04-09 |
| CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas Theralight crosslinking and Riboflavin - Keratoconus | Phase 2 | Terminated | Cxlusa | 1324 | 2013-01-01 | 2018-10-12 |
| Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). UV-X 1000 (3 mW/cm²), UV-X 2000 (9 mW/cm²), riboflavin with hydroxypropyl methylcellulose - Keratoconus, Corneal Ectasia | Phase 1 / Phase 2 | Unknown | Oslo University Hospital | 40 | 2012-08-01 | 2016-08-30 |
| Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis Riboflavin - Chemical Injuries, Unspecified Complication of Corneal Transplant | Phase 1 / Phase 2 | Completed | Joseph B. Ciolino, MD | 1 | 2012-03-01 | 2019-10-21 |
| UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia UV-X Light, Riboflavin - Keratoconus, Ectasia | Phase 2 | Unknown | Mercy Center for Corrective Eye Surgery | 250 | 2011-03-01 | 2011-03-29 |
Showing 20 of 27. Sign in to see all of them.
Keratoconus (11) · Dilatation, Pathologic (4) · Corneal Diseases (2) · Corneal Ulcer (2) · Keratitis (2) · Acidosis, Lactic (1) · Alcoholism (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Brain Concussion (1) · Chronic Pain (1) · Cognitive Dysfunction (1) · Delayed Emergence from Anesthesia (1) · Delirium (1) · Emergence Delirium (1)
Joseph B. Ciolino, MD (2) · Peschke GmbH (2) · Price Vision Group (2) · Cxlusa (1) · Eye Specialists of Indiana (1) · Georgetown University (1) · Instituto de Cardiologia do Rio Grande do Sul (1) · Ionis Pharmaceuticals, Inc. (1) · Johns Hopkins University (1) · Mercy Center for Corrective Eye Surgery (1) · New York State Psychiatric Institute (1) · Ohio State University (1) · Oregon Health and Science University (1) · Oslo University Hospital (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1)
United States (17) · Brazil (1) · Canada (1) · Iran (1) · Netherlands (1) · Norway (1) · Spain (1) · United Kingdom (1)
Bala Ambati (2) · Yvette Viscuso (2) · Aleksandar Stojanovic, MD (1) · Brandon Cornejo, MD, PhD (1) · Carlos AM Gottschall, MD MSc PhD (1) · Daniel M. Moreira, MD. MSc (1) · Daniel M. Moreira, MD. MSc. (1) · Ezra Maguen, M.D. (1) · Fateme Alipour, MD (1) · Francis Price, MD (1) · Francis W Price, MD (1) · Hermie J.M. Harmsen, PhD (1) · Hilary J Powers, PhD (1) · James Salz, M.D. (1) · Johann Gudjonsson, MD (1)
PMID 16765803, PMID 16952090, PMID 18471635, PMID 18811118, PMID 20138607, PMID 20164744, PMID 22741619, PMID 27899371, PMID 28325070, PMID 29203068, PMID 32532654, PMID 32557558, PMID 35943883
2017 (1), P50DA009236 (1), R21AG050850 (1)